In a kinase-dependent manner, BCR-ABL1 induces SCFSkp2 expression through the PI3K pathway (213), promoting the degradation of nuclear p27Kip1, thus compromising its tumor-suppressor activity. The gene discussed is CDKN1B; the disease is neoplasm.